全文获取类型
收费全文 | 3700篇 |
免费 | 277篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 104篇 |
妇产科学 | 68篇 |
基础医学 | 653篇 |
口腔科学 | 36篇 |
临床医学 | 431篇 |
内科学 | 823篇 |
皮肤病学 | 102篇 |
神经病学 | 449篇 |
特种医学 | 65篇 |
外国民族医学 | 4篇 |
外科学 | 320篇 |
综合类 | 23篇 |
预防医学 | 322篇 |
眼科学 | 26篇 |
药学 | 209篇 |
中国医学 | 16篇 |
肿瘤学 | 314篇 |
出版年
2023年 | 21篇 |
2022年 | 44篇 |
2021年 | 97篇 |
2020年 | 49篇 |
2019年 | 71篇 |
2018年 | 98篇 |
2017年 | 60篇 |
2016年 | 72篇 |
2015年 | 98篇 |
2014年 | 145篇 |
2013年 | 159篇 |
2012年 | 251篇 |
2011年 | 302篇 |
2010年 | 156篇 |
2009年 | 143篇 |
2008年 | 260篇 |
2007年 | 242篇 |
2006年 | 195篇 |
2005年 | 246篇 |
2004年 | 200篇 |
2003年 | 190篇 |
2002年 | 189篇 |
2001年 | 72篇 |
2000年 | 44篇 |
1999年 | 52篇 |
1998年 | 28篇 |
1997年 | 46篇 |
1996年 | 31篇 |
1995年 | 27篇 |
1994年 | 24篇 |
1993年 | 15篇 |
1992年 | 34篇 |
1991年 | 29篇 |
1990年 | 38篇 |
1989年 | 21篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 19篇 |
1985年 | 18篇 |
1984年 | 12篇 |
1983年 | 13篇 |
1981年 | 8篇 |
1979年 | 13篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1972年 | 7篇 |
1971年 | 11篇 |
1969年 | 7篇 |
排序方式: 共有3982条查询结果,搜索用时 15 毫秒
51.
Nutrition and laryngeal cancer 总被引:3,自引:0,他引:3
The main etiologic factors of cancers of the larynx and hypopharynx are alcohol and tobaeco, and their prevalence in different populations explains, to a large extent, the wide variations in incidence observed around the world. Besides these two main risk factors, however, diet also seems to play a role in determining the risk of these cancers. There is consistent evidence that low consumption of fruit and vegetables is associated with higher risk, after statistical adjustment for alcohol and tobacco. Consumption of vegetable oils and fish and a moderately high polyunsaturated/saturated fatty acid ratio (P/S ratio) were reported to be associated with reduced risk. Low intake of vitamin C, -carotene and vitamin E were reported consistently to be associated with higher laryngeal cancer risk, but there was no clear evidence that these micronutrients are better predictors of cancer risk than the principal food groups from which their intake levels were estimated, i.e., fruits, vegetables, vegetable oils, and fish. Given the overwhelming role of tobacco and alcohol in the etiology of these cancers and the extremely low incidence among nonsmokers/nondrinkers, the available studies provide no estimate of the role of diet in subjects not exposed to these factors. The evidence indicates, however, that, in the presence of tobacco and/or alcohol, low intake of fruit and vegetables may account for 25 to 50 percent of the cases among men. 相似文献
52.
Pascal Jézéquel Mario Campone Henri Roché Wilfried Gouraud Catherine Charbonnel Gabriel Ricolleau Florence Magrangeas Stéphane Minvielle Jean Genève Anne-Laure Martin Régis Bataille Loïc Campion 《Breast cancer research and treatment》2009,116(3):509-520
Currently, no prognostic gene-expression signature (GES) established from node-positive breast cancer cohorts, able to predict evolution after systemic adjuvant chemotherapy, exists. Gene-expression profiles of 252 node-positive breast cancer patients (median follow-up: 7.7 years), mostly included in a randomized clinical trial (PACS01), receiving systemic adjuvant regimen, were determined by means of cDNA custom array. In the training cohort, we established a GES composed of 38 genes (38-GES) for the purpose of predicting metastasis-free survival. The 38-GES yielded unadjusted hazard ratio (HR) of 4.86 (95% confidence interval = 2.76–8.56). Even when adjusted with the best two clinicopathological prognostic indexes: Nottingham prognostic index (NPI) and Adjuvant!, 38-GES HRs were 3.30 (1.81–5.99) and 3.40 (1.85–6.24), respectively. Furthermore, 38-GES improved NPI and Adjuvant! classification. In particular, NPI intermediate-risk patients were divided into 2/3 close to low-risk group and 1/3 close to high-risk group (HR = 6.97 [2.51–19.36]). Similarly, Adjuvant! intermediate-risk patients were divided into 2/3 close to low-risk group and 1/3 close to high-risk group (HR = 4.34 [1.64–11.48]). The 38-GES was validated on gene-expression datasets from three external node-positive breast cancer subcohorts (n = 224) generated from different microarray platforms, with HR = 2.95 (1.74–5.01). Moreover, 38-GES showed prognostic performance in supplementary cohorts with different lymph-node status and endpoints (1,040 new patients). The 38-GES represents a robust tool able to type systemic adjuvant treated node-positive patients at high risk of metastatic relapse, and is especially powerful to refine NPI and Adjuvant! classification for those patients. 相似文献
53.
54.
Benjamin Lebeau Maïka Jangal Tiejun Zhao Cheng Kit Wong Nolan Wong Eduardo Cepeda Caedo Steven Hbert Adriana Aguilar-Mahecha Catherine Chabot Marguerite Buchanan Rachel Catterall Luke McCaffrey Genevive Deblois Claudia Kleinman Morag Park Mark Basik Michael Witcher 《Proceedings of the National Academy of Sciences of the United States of America》2022,119(36)
55.
Sara Berradja Nicolas Turmel Claire Hentzen Rebecca Haddad Gabriel Miget Matthieu Grasland Camille Chesnel Genevive Nadeau Gerard Amarenco 《Canadian Urological Association journal》2022,16(9):E468
IntroductionThis study aimed to empirically validate a French version of the Neurogenic Bladder Symptoms Score-Short From (NBSS-SF), a psychometric multidimensional tool to assess lower urinary tract symptoms (LUTS) for patients with a neurological condition.MethodsOne hundred and five participants with multiple sclerosis or spinal cord injury prospectively completed the questionnaire at baseline and 7–14 days later. The α coefficient of Cronbach (internal consistency) and the intraclass correlation coefficient (ICC) (test-retest reliability) were calculated.ResultsThe internal consistency for the overall questionnaire was high (Cronbach’s α coefficients from 0.79), while coefficients for each subscale were variable (urinary incontinence 0.91; storage and voiding 0.69; consequences 0.25). For test-retest reliability, 88/105 (84%) patients filled and sent back their questionnaire 10 days (±3.6 days) after baseline version. ICC was 0.90 for the total score and was 0.73 for the urinary incontinence subdomain, 0.79 for storage and voiding, and 0.75 for consequences.ConclusionsThe psychometric qualities of the French version of the NBSS-SF are well-supported, thus providing a valid tool to measure bladder symptoms across three different domains in patients with neurogenic bladder. 相似文献
56.
Tenna Vesterman Henriksen Thomas Reinert Mads Heilskov Rasmussen Christina Demuth Uffe Schou Lve Anders Husted Madsen Kre Andersson Gotschalck Lene Hjerrild Iversen Claus Lindbjerg Andersen 《Molecular oncology》2022,16(20):3654
Circulating tumour DNA (ctDNA) detection for postoperative risk stratification in cancer patients has great clinical potential. However, low ctDNA abundances complicates detection. Multitarget (MT) detection strategies have been developed to increase sensitivity. Yet, empirical evidence supporting performance gains of MT vs. single‐target (ST) strategies in a postoperative setting is limited. We compared ctDNA detection in 379 paired plasma samples from 112 stage II–III colorectal cancer patients by ST digital PCR and MT sequencing of 16 patient‐specific variants. The strategies exhibited good concordance (90%, Cohen''s Kappa 0.79), with highly correlated ctDNA quantifications (Pearson r = 0.985). A difference was observed in ctDNA detection preoperatively (ST 72/92, MT 88/92). However, no difference was observed immediately after surgery in recurrence (ST 11/22, MT 10/22) or nonrecurrence (both 2/34) patients. In serial samples, detection was similar within recurrence (ST 13/16, MT 14/16) and nonrecurrence (ST 3/49, MT 1/49) patients. Both approaches yielded similar lead times to standard‐of‐care radiology (ST 4.0 months, MT 4.1 months). Our findings do not support significant performance gains of the MT strategy over the ST strategy for postoperative ctDNA detection. 相似文献
57.
58.
59.
Cécile Q.T. Nguyen Marie-Hélène Denis Miguel Chagnon Rémi Rabasa-Lhoret Geneviève Mailhot 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):277-285
Background and aimsDeterioration of anthropometric and lung function parameters was shown to precede the onset of cystic fibrosis-related diabetes (CFRD) in adults. In children, studies have been conducted in small cohorts with relatively short observation period. Study objectives were to document the longitudinal trends of anthropometric, pulmonary, nutritional and metabolic parameters from cystic fibrosis (CF) diagnosis to the ascertainment of abnormal glucose tolerance and identify parameters associated with the incidence of such abnormalities in a pediatric CF cohort.Methods and resultsRetrospective cohort study of 281 children with CF. Longitudinal trends of anthropometric, lung function, nutritional and metabolic data were generated from CF diagnosis to the ascertainment of abnormal glucose tolerance defined as the presence of either impaired glucose tolerance (IGT), unconfirmed CFRD or CFRD. Cox models and Kaplan–Meier curves were used to identify factors associated with developing abnormal glucose tolerance.Forty-five percent of cohort had normal glucose tolerance (NGT), 27% IGT, 10% unconfirmed CFRD and 18% CFRD. Children who developed CFRD displayed lower height z-scores from a very early age. Conversely, HbA1c levels began to rise closer to CFRD ascertainment. Height z-scores (HR: 0.45; CI 95% [0.29–0.69]) and HbA1c (HR: 2.43; CI 95% [1.86–3.18]) in years preceding ascertainment were associated with the risk of developing CFRD.ConclusionChildren who developed CFRD display distinctive trends for height z-scores from a very early age, whereas HbA1c appears as a marker of established glucose metabolism derangements. 相似文献
60.
Marie-Ève Boulay Claudia Pruneau-Pomerleau Hélène Villeneuve Francine Deschesnes Lyne Ringuette 《The Journal of asthma》2018,55(3):231-243
Background: A “frequent exacerbator phenotype” has been described, mostly in the population of patients with severe asthma. Further data are needed on such exacerbation-prone patients in milder asthma. Aim: To compare the characteristics of frequent and nonfrequent exacerbators in asthma of different severities and to assess the stability of the exacerbator status. Methods: This was an observational study comparing baseline data from frequent (≥2 exacerbations in the past year) and nonfrequent (<2 exacerbations in the past year) exacerbators. Patients were also followed up for one year. Information regarding clinical, physiologic, and inflammatory characteristics was collected at baseline and one-year follow-up. Results: Forty-seven frequent and 53 nonfrequent exacerbators were recruited. No specific clinical, physiologic, or inflammatory characteristic was observed in the frequent as compared to the nonfrequent exacerbators at baseline. Fifty-eight percent of patients reporting frequent exacerbations at baseline remained in this group after one year of follow-up. Forty-two and 62% of patients with, respectively, mild-to-moderate asthma and severe asthma had frequent exacerbations. In a post hoc analysis according to asthma severity, frequent exacerbators with severe asthma had a higher body mass index and poorer asthma control, although they reported higher adherence to medication, in comparison to frequent exacerbators with mild-to-moderate asthma. No specific characteristics could discriminate between frequent and nonfrequent exacerbators of the same asthma severity. Conclusions: Frequent exacerbators with severe asthma present some specific characteristics not observed in frequent exacerbators with mild-to-moderate disease. However, the latter group should be identified to reassess treatment needs and potential contributing factors. 相似文献